The objective of this proposal is the characterization of the structure, function and receptor biology of alpha2-macroglobulin (alpha2M), a plasma proteinase inhibitor important in the regulation of proteinases of each of the four mechanistic classes. The scope of the proposal has been narrowed from previous years where projects focused on serine proteinase inhibitors, inter-alpha-trypsin inhibitor, chemically synthesized inhibitors of coagulation factors and alpha2M. Recent studies of this and other laboratories establish a major role of alpha2M-proteinase complexes in the regulation of tumor kill, inflammation and immune function via well-established signal transduction pathways following receptor recognition of alpha2M-proteinase complexes. The focus of HL-24066 will remain on structure/function and not the signal transduction pathway. Studies during the last five years establish that the alpha2M receptor recognition site is in the carboxyl terminal. It is now proposed to study the role of this region in receptor recognition by use of expression and mutational analysis and by use of synthetic peptides. The ability of alpha2M to regulate macrophage immune function will be studied in an antigen presentation assay. The goal of these studies is to determine whether antigen uptake by macrophages is facilitated as a result of co-incorporation of antigens in alpha2M which occurs during proteinase attack on alpha2M. It is further proposed to obtain direct information on the nature of proteinases bound to alpha2M under biological conditions. These studies will be made possible by the fact that, in human cirrhosis, alpha2M-proteinase complexes circulate in plasma and can be isolated and the bound proteinase sequenced. These studies are important since all previous investigations provide only inferential evidence about the in vivo spectrum of activity of alpha2M. The final studies will further probe the evolution of the receptor recognition site of alpha2M. In conjunction with these studies, efforts will be directed towards understanding when complement precursor-like lytic activity and proteinase inhibitory activity diverged into separate pathways. Recent data from this laboratory establish that both activities reside in the same molecule, now named limac. During the course of evolution, gene duplication and divergence occurred so that a family of complement proteins which are alpha2M homologues (C3, C4 and C5) arose. Human complement proteins do not inhibit proteinases and human alpha2M does not possess a cell lytic capability.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37HL024066-15
Application #
3485808
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1979-07-01
Project End
1997-06-30
Budget Start
1993-07-01
Budget End
1994-06-30
Support Year
15
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Duke University
Department
Type
Schools of Medicine
DUNS #
071723621
City
Durham
State
NC
Country
United States
Zip Code
27705
Jockheck-Clark, Angela R; Bowers, Edith V; Totonchy, Mariam B et al. (2010) Re-examination of CD91 function in GRP94 (glycoprotein 96) surface binding, uptake, and peptide cross-presentation. J Immunol 185:6819-30
Gonzalez-Gronow, Mario; Cuchacovich, Miguel; Francos, Rina et al. (2010) Antibodies against the voltage-dependent anion channel (VDAC) and its protective ligand hexokinase-I in children with autism. J Neuroimmunol 227:153-61
Misra, Uma Kant; Mowery, Yvonne; Kaczowka, Steven et al. (2009) Ligation of cancer cell surface GRP78 with antibodies directed against its COOH-terminal domain up-regulates p53 activity and promotes apoptosis. Mol Cancer Ther 8:1350-62
Benvegnu, Stefano; Franciotta, Diego; Sussman, Josh et al. (2009) Prion protein paralog doppel protein interacts with alpha-2-macroglobulin: a plausible mechanism for doppel-mediated neurodegeneration. PLoS One 4:e5968
Bowers, Edith V; Horvath, Jeffrey J; Bond, Jennifer E et al. (2009) Antigen delivery by alpha(2)-macroglobulin enhances the cytotoxic T lymphocyte response. J Leukoc Biol 86:1259-68
Misra, U K; Wang, F; Pizzo, S V (2009) Transcription factor TFII-I causes transcriptional upregulation of GRP78 synthesis in prostate cancer cells. J Cell Biochem 106:381-9
Gonzalez-Gronow, Mario; Kaczowka, Steven; Gawdi, Govind et al. (2008) Dipeptidyl peptidase IV (DPP IV/CD26) is a cell-surface plasminogen receptor. Front Biosci 13:1610-8
Lillis, Anna P; Greenlee, Mallary C; Mikhailenko, Irina et al. (2008) Murine low-density lipoprotein receptor-related protein 1 (LRP) is required for phagocytosis of targets bearing LRP ligands but is not required for C1q-triggered enhancement of phagocytosis. J Immunol 181:364-73
Misra, Uma Kant; Pizzo, Salvatore Vincent (2008) Heterotrimeric Galphaq11 co-immunoprecipitates with surface-anchored GRP78 from plasma membranes of alpha2M*-stimulated macrophages. J Cell Biochem 104:96-104
Pizzo, Salvatore V (2008) Annexin 2/factor xa-mediated signal transduction. Circ Res 102:389-91

Showing the most recent 10 out of 158 publications